Gram-positive sepsis: Mechanisms and differences from gram-negative sepsis

Infectious Disease Clinics of North America

Volumn 13, Issue 2, 1999, Pages 397-412

  Sriskandan, S ^a   Cohen, J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; ENDOTOXIN; HEMOLYSIN; HYALURONIC ACID; PEPTIDOGLYCAN; SUPERANTIGEN; TEICHOIC ACID; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; CELL WALL; DIFFERENTIAL DIAGNOSIS; GENE CONTROL; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; MOLECULAR GENETICS; NONHUMAN; RECEPTOR BINDING; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 0033035861     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70082-9     Document Type: Article

References (100)

1. A. Abdelnour T. Bremell R. Holmdahl Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1 producing staphylococci Eur J Immunol 24 1994 1161 1166
2. A.J. Ahmed J.A. Kruse M.T. Haupt Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock Crit Care Med 19 1991 1520 1525
3. C.D. Ashbaugh H.B. Warren V.J. Carey Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection J Clin Invest 102 1998 550 560
4. Ben Nasr A. H. Herwald W. Muller-Esterl Human kininogens interact with M protein, a bacterial surface protein and virulence determinant Biochem J 305 1995 173 180
5. Bette M. Schafer M.K.-H. van Rooijen N. Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen J Exp Med 178 1993 1531 1540
6. Bochud P.-Y. T. Calandra P. Francioli Bacteremia due to viridans streptococci in neutropenic patients: A review Am J Med 97 1994 256 264
7. L.C. Casey R.A. Balk R.C. Bone Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann Intern Med 119 1993 771 778
8. Y. Choi J.A. Lafferty J.R. Clements Selective expansion of T cells expressing Vβ2 in toxic shock syndrome J Exp Med 172 1990 981 984
9. M.G. Cleveland J.D. Gorham T.L. Murphy Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway Infect Immun 64 1996 1906 1912
10. J.B. Dale R.G. Washburn M.B. Marques Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci Infect Immun 64 1996 1495 1501
11. de Azavedo J.C.S. T.J. Foster P.J. Hartigan Expression of the cloned toxic shock syndrome toxin-1 gene (tst) in vivo with a rabbit uterine model Infect Immun 50 1985 304 309
12. De Kimpe S.J. M. Kengatharan C. Thiemerman The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure Proc Natl Acad Sci U S A 92 1995 10359 10363
13. DeLa Cadena R.A. K.J. Laskin R.A. Pixley Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation Am J Physiol 260 1991 G213 G219
14. K. Diener P. Tessier J. Fraser Induction of acute inflammation in vivo by staphylococcal superantigens I: Leukocyte recruitment occurs independently of T lymphocytes and major histocompatibility complex class II molecules Lab Invest 78 1998 647 565
15. A.S.M. Dofferhof E. Vellenga P.C. Limburg Tumour necrosis factor (cachectin) and other cytokines in septic shock: A review of the literature Neth J Med 38 1991 46 63
16. R. Dziarski Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages J Biol Chem 269 1994 20431 20436
17. S. Endo K. Inada Y. Yamada Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock Crit Care Med 22 1994 949 955
18. B.K. English C.C. Patrick S.L. Orlicek Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages J Infect Dis 174 1996 1348 1351
19. T. Evans A. Carpenter A. Silva Inhibition of nitric oxide synthase in experimental gram-negative sepsis J Infect Dis 169 1994 343 349
20. T.J. Evans The role of macrophages in septic shock Immunobiology 195 1996 655 659
21. C.J. Fisher S.M. Opal Dhainaut J.-F. Influence of a murine anti-TNF monoclonal antibody (CB0006) on cytokine levels in patients in sepsis Crit Care Med 21 1993 318 327
22. S. Florquin Z. Amraoui C. Dubois The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice J Exp Med 180 1994 1153 1158
23. S. Florquin Z. Amraoui M. Goldman T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-γ and interleukin-10 secretion Eur J Immunol 25 1995 1148 1153
24. Y. Fong S.F. Lowry Tumor necrosis factor in the pathophysiology of infection and sepsis Clin Immunol Immunopathol 55 1990 157 170
25. Gupta D. Jin Y.-P. R. Dziarski Peptidoglycan induces transcription and secretion of TNF-α and activation of lyn, extracellular signal-related kinase, and rsk signal transduction proteins in mouse macrophages J Immunol 255 1995 2620 2630
26. H. Herwald M. Colin W. Muller-Esterl Streptococcal cysteine proteinase releases kinins: A novel virulence mechanism J Exp Med 184 1996 673 665
27. H. Herwald M. Morgelin A. Olsen Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases Nat Med 4 1998 298 302
28. D. Heumann C. Barras A. Severin Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes Infect Immun 62 1994 2715 2721
29. Himanen J.-P. L. Pyhala Olander R.-M. Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg) Journal of General Microbiology 139 1993 2659 2665
30. C.W. Hoge B. Schwartz D.F. Talkington The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome JAMA 269 1993 384 389
31. O. Hultgren M. Kopf A. Tarkowski Staphylococcus aureus -induced septic arthritis and septic death is decreased in IL-4-deficient mice: Role of IL-4 as promoter for bacterial growth J Immunol 160 1998 5082 5087
32. Husmann L.K. Yung D.-L. S.K. Hollinshead Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia Infect Immun 65 1997 1422 1430
33. L. Johannsen Biological properties of bacterial peptidoglycan APMIS 101 1993 337 344
34. V. Kapur M.W. Majesky Li L.-L. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes Proc Natl Acad Sci U S A 90 1993 7676 7680
35. V. Kapur S. Topouzis M.W. Majesky A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin Microb Pathog 15 1993 327 346
36. H. Kieft A.I.M. Hoepelman W. Zhou The sepsis syndrome in a Dutch university hospital Arch Intern Med 153 1993 2241 2247
37. Y.B. Kim D.W. Watson A purified group A streptococcal pyrogenic exotoxin J Exp Med 131 1970 611 628
38. T. Kobayashi T. Tani T. Yokota Plasma levels of peptidoglycan detected with silkworm larvae plasma in septic patients [abstract 556] Shock 7 1997 139
39. S.M. Larkin D.N. Williams M.T. Ostreholm Toxic shock syndrome: Clinical, laboratory, and pathologic findings in fatal cases Ann Intern Med 96 1982 858 864
40. G. Lemm J. Carlet J. Cohen Cytokine levels in patients with the sepsis syndrome treated with a monoclonal antibody to human TNFα (Intersept trial) Clinical Intensive Care Suppl 6 1995 68
41. S.N. Lichtman S. Bachmann S.R. Munoz Bacterial cell wall polymers (peptidoglycan-polysaccharide) cause reactivation of arthritis Infect Immun 61 1993 4645 4653
42. M.O. Lonchampt M. Auguet S. Delaflotte Lipoteichoic acid: A new inducer of nitric oxide synthase J Cardiovasc Pharmacol 20 suppl 12 1992 S145 S147
43. J.D. MacMicking C. Nathan G. Hom Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase Cell 81 1995 641 650
44. H. Maede T. Okamoto T. Akaike Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals Biol Chem 379 1998 193 200
45. J.D. Marks C.B. Marks J.M. Luce Plasma tumor necrosis factor in patients with septic shock Am Rev Respir Dis 141 1990 94 97
46. P. Marrack M. Blackman E. Kushnir The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells J Exp Med 171 1990 455 464
47. G.D. Martich R.L. Danner M. Ceska Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents J Exp Med 173 1991 1021 1024
48. R.A. Martin A.T. Silva J. Cohen Effect of anti-TNF-α treatment in an antibiotic treated murine model of infection due to Streptococcus pyogenes FEMS Microbiol Lett 79 1992 313 322
49. J.W. Mason U. Kleeberg P. Dolan Plasma kallikrein and Hageman factor in gram-negative bacteremia Ann Intern Med 73 1970 545 551
50. E. Mattson L. Verhage J. Rollof Peptidoglycan and teichoic acid from Staphylococcus aureus stimulate human monocytes to release tumour necrosis factor-α, interleukin-1β and interleukin-6 7 1993 288 281
51. I.B. McInnes B. Leung Wei X.-Q. Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase J Immunol 160 1998 308 315
52. M.E. Melish S. Murata C. Fukunga Endotoxin is not an essential mediator in toxic shock syndrome Rev Infect Dis 11 suppl 1 1989 S219 S228
53. R.M. Mesters P.M. Mannucci R. Coppola Factor VIIa and antithrombin II activity during severe sepsis and septic shock in neutropenic patients Blood 88 1996 881 886
54. C. Michie A. Scott J. Cheesbrough Streptococcal toxic shock-like syndrome: Evidence of superantigen activity and its effects on T lymphocyte subsets in vivo Clin Exp Immunol 98 1994 140 144
55. A. Molla T. Yamamoto T. Akaike Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases J Biol Chem 264 1989 10589 10594
56. S. Moncada R.M.J. Palmer E.A. Higgs Nitric oxide: Physiology, pathophysiology and pharmacology Pharmacology Review 43 1991 109 142
57. J.M. Musser Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes Prep Biochem Biotechnol 27 2&3 1997 143 172
58. Natanson C. Danner R.L. Elin R.J. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphyococcus aureus challenges in a canine model of human septic shock J Clin Invest 83 1989 243 251
59. B. Neumann B. Engelhardt H. Wagner Induction of acute inflammatory lung injury by staphylococcal enterotoxin B J Immunol 158 1997 1862 1871
60. T. Onta M. Sashida N. Fujii Induction of acute arthritis in mice by peptidoglycan derived from gram-positive bacteria and its possible role in cytokine production Microbiol Immunol 37 1993 573 582
61. Opal SM, Cohen J: Clinical gram-positive sepsis: Does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med, in press
62. J.E. Parillo Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy Ann Intern Med 113 1990 227 242
63. J. Parsonnet Mediators in the pathogenesis of toxic shock syndrome: Overview Rev Infect Dis 11 suppl 1 1989 S263 S269
64. K. Pfeffer T. Matsuyama T.M. Kundig Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infections Cell 73 1993 457 467
65. J. Pugin D. Heumann A. Tomasz CD14 is a pattern recognition receptor Immunity 1 1994 509 516
66. R.L. Rabin M.M. Bieber N.N.H. Teng Lipopolysaccharide and peptidoglycan share binding sites on human peripheral blood monocytes J Infect Dis 168 1993 135 142
67. T. Renno M. Hahne H.R. MacDonald Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo J Exp Med 181 1995 2283 2287
68. Renzi P.M. Lee C.-H. A comparative study of biological activities of lipoteichoic acid and lipopolysaccharide Journal of Endotoxin Research 2 1995 431 441
69. B. Rozalska T. Wadstrom Interferon-gamma, interleukin-1 and tumour necrosis factor-alpha synthesis during experimental murine staphylococcal infection FEMS Immunol Med Microbiol 7 1993 145 152
70. E. Sakienne T. Bremell A. Tarkowski Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis Clin Exp Immunol 110 1997 370 377
71. P.M. Schlievert Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C Infect Immun 36 1982 123 128
72. P.M. Schlievert A.P. Assimacopoulos P.P. Cleary Severe invasive group A streptococcal disease: Clinical description and mechanisms of pathogenesis J Lab Clin Med 127 1996 13 22
73. H.M. Schrager S. Alberti C. Cywes Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes J Clin Invest 101 1998 1708 1716
74. H.M. Schrager J.G. Rheinwald M.R. Wessels Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection J Clin Invest 98 1996 1954 1958
75. D.V. Seal D. Kingston Streptococcal necrotizing fasciitis: Development of an animal model to study its pathogenesis Br J Exp Path 69 1988 831 813
76. W. Seeger H. Schutte F. Grimminger Bacterial Exotoxins and Sepsis Reinhart K. Eyrich K. Sprung C. Sepsis. Current Perspectives in Pathophysiology and Therapy 1994 Springer-Verlag Berlin 61 85
77. Sloane R. de Azavedo J.C.S. J.P. Arbuthnott A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model FEMS Microbiol Lett 62 2–3 1991 239 244
78. S. Sriskandan J. Cohen The pathogenesis of septic shock J Infect 30 1995 201 206
79. S. Sriskandan J. Cohen Tumour Necrosis Factor as a Therapeutic Target in Sepsis Reinhart K. Eyrich K. Sprung C. Sepsis. Current Perspectives in Pathophysiology and Therapy 1994 Springer-Verlag Berlin 337 348
80. S. Sriskandan D. Moyes J. Cohen Detection of circulating bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic-shock syndrome Lancet 348 1996 1315 1316
81. S. Sriskandan D. Moyes G. Lemm Lymphotoxin-α (TNF-β) during sepsis Cytokine 8 1996 933 937
82. S. Sriskandan D. Moyes L.K. Buttery The role of nitric oxide in experimental murine septic shock due to SPEA-producing Streptococcus pyogenes Infect Immun 65 1997 1767 1772
83. Sriskandan S, Moyes D, Kemball-Cook G, et al: Sepsis with Streptococcus pyogenes is associated with activation of factor XII and the host contact system [abstract]. Abstracts and Proceedings of the 37th Interscience Conference on Antimicrobials and Chemotherapy, Toronto, 1997, abstract B55
84. S. Sriskandan D. Moyes L.K. Buttery Streptococcal pyrogenic exotoxin A (SPEA) release, distribution and role in a murine model of fasciitis and multi-organ failure due to Streptococcus pyogenes J Infect Dis 173 1996 1399 1407
85. T.J. Standiford D.A. Arenberg J.M. Danforth Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: A cellular and molecular analysis Infect Immun 62 1994 119 125
86. D.L. Stevens A.E. Bryant S.P. Hackett Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure J Infect Dis 173 1996 619 626
87. R.L. Stone P.M. Schlievert Evidence for the involvement of endotoxin in toxic shock syndrome J Infect Dis 155 1987 682 689
88. H. Takada Y. Kawbata M. Tamura Cytokine induction by extracellular products of oral viridans group streptococci Infect Immun 61 1993 5252 5260
89. P.A. Tessier P.H. Naccache K.R. Diener Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-α J Immunol 161 1998 1204 1211
90. G. Teti G. Mancuso F. Tomasello Production of tumor necrosis factor-α and interleukin-6 in mice infected with group B streptococci Circulatory Shock 38 1992 138 144
91. C.P. Timmerman E. Mattson L. Martinez-Martinez Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans Infect Immun 61 1993 4167 4172
92. G. Wakabayashi J.A. Gelfand W.K. Jung Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia J Clin Invest 87 1991 1925 1935
93. R. Watanabe-Ohnishi D.E. Low A. McGreer Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome J Infect Dis 171 1995 74 84
94. D.W. Watson Host-parasite factors in group A streptococcal infections J Exp Med 111 1960 255 285
95. Wei X.-Q. I.G. Charles A. Smith Altered immune responses in mice lacking inducible nitric oxide synthase Nature 375 1995 408 411
96. B. Weidemann H. Brade E.T. Rietschl Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures Intensive Care Medicine 20 suppl 1 1994 S10
97. J.B. Wiles F.B. Cerra J.H. Siegel The systemic septic response: Does the organism matter? Crit Care Med 8 1980 55 60
98. Working Group on Severe Streptococcal Infections Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition JAMA 269 1993 390 391
99. H. Xu J.A. Gonzalo St Pierre Y. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice J Exp Med 180 1994 95 109
100. T. Yokoyama L. Vaca R.D. Rossen Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart J Clin Invest 92 1993 2303 2012